2025-09 monthly summary: Delivered targeted business value and robust technical improvements across the hartwigmedical/scripts and hartwigmedical/hmftools repositories. Implemented versioned Remark pipeline updates with latest RefSeq canonical transcripts to improve analysis accuracy and reproducibility; extended pipeline tooling to flexibly resolve non-standard directory formats, increasing compatibility with varied outputs; documented and aligned gene ID mappings for HG37/HG38 and updated PEACH config to include UGT1A1, reducing misannotations in pharmacogenomics workflows. These changes enhance data integrity, streamline deployment, and enable faster, more reliable downstream analyses and reporting.

July 2025 performance summary: Delivered cross-repo improvements at hartwigmedical across hmftools and scripts, emphasizing documentation accuracy, test coverage, and robust tooling. Key features include Esvee tool documentation alignment to the .esvee extension, expanded testing for somatic variant and data comparisons, a new comparative genomics analysis suite, and robust vCompar CLI enhancements. Also introduced a warning mechanism for potentially missed deletions and completed a minor release update to the OncoAct Panel remarks workflow. These efforts improved reliability, reduced validation overhead, and enabled faster, more accurate cross-dataset analyses.

June 2025 monthly summary focusing on key accomplishments, business value, and technical achievements across two repositories. Delivered reliability improvements, data integrity fixes, and workflow alignment that reduce operational risk and accelerate accurate analyses for downstream decision-making. Key outcomes by repository: - hartwigmedical/scripts: Implemented bucket mounting reliability by using sudo to create the target directory, preventing mounting failures due to permissions. Enhanced OncoAct remarks with CRLF2 handling exclusions, unreliable marking, and terminology updates from purity to mTCP; updated comparisons tooling to SvTmb v1.3.4 and added a vChord low-purity (HRD) warning. - hartwigmedical/hmftools: Fixed SvTmb calculation data retrieval to ensure correct data is used; resolved SV loading test assertion discrepancies to reflect actual SV data, improving test stability and data integrity. Impact: - Reduced mounting failures and permission-related incidents, improving data ingestion reliability. - Improved data curation quality and consistency through workflow and terminology updates. - Correct SvTmb analytics and more robust SV-related testing, increasing trust in comparative analyses for clinical insights. - Faster issue detection and triage with automated HRD warnings and aligned tooling across workflows. Technologies and skills demonstrated: - Linux permissions and sudo usage, scripting and workflow updates. - Versioned tooling and image alignment (v1.3.4) for SvTmb comparisons. - Data quality assurance and test robustness in SvTmb and SV data pipelines. - Cross-repo collaboration and change management with clear commit traceability.

May 2025 delivered concrete business-value improvements across two repos. In hmftools, corrected fusion classification in REPORTABLE mode and extended classification logic with isPass() to support VALUE vs REF_ONLY differentiation. In scripts, shipped OncoAct panel remarks automation and auto-compare workflow enhancements, including automated remarks pipeline, low exon-coverage warnings, clarified QC messages, executable scripts, and more robust argument handling. These changes improve accuracy, reduce manual steps, and provide clearer user feedback.

April 2025 monthly summary highlighting key deliverables in hmftools and scripts, with a focus on business value, technical achievements, and cross-repo collaboration. The month centered on delivering robust reporting capabilities, correcting critical data flows, and updating tooling to ensure reproducibility and up-to-date integrations across CI pipelines.

March 2025 performance summary across hartwigmedical/pipeline5, hmftools, and scripts. Delivered key reliability and correctness improvements including permission fixes for public image creation, multi-tool version hotfixes, and robust pipeline completion on error. Implemented frameshift annotation accuracy improvements in PAVE, corrected fusion plot domain filtering, and enhanced auto-compare workflow argument handling. Result: reduced build failures, fewer deadlocks, more accurate annotations and visualizations, and safer, faster CI/CD across the stack.

February 2025 monthly summary for hartwigmedical/pipeline5: Delivered targeted pipeline upgrades and test environment alignment, along with smoke test truthset updates to preserve test accuracy in the face of resource definition changes. These changes improved CI reliability, build reproducibility, and overall pipeline stability, enabling safer and faster releases.

Monthly summary for 2025-01 focusing on delivered features, bug fixes, and technical accomplishments across hmftools, scripts, and pipeline5. Emphasis on improving clarity, data integrity, security posture, and runtime performance to deliver business value and maintainable code.

December 2024 performance summary: Delivered backward compatibility for chord prediction data in hmftools by extending the ChordComparer to recognize current and legacy file naming formats. This enables data compatibility with historical datasets, reduces data wrangling, and supports analytics continuity. No major bugs fixed this month; main focus was feature delivery and code quality improvements. The changes improved data interoperability and reduced manual maintenance for historical chord data pipelines.

Month 2024-11 — Delivered key features and security improvements across hmftools and scripts, improving data integrity, reliability, and security posture. Highlights include robust flagstat discovery and flexible file path handling in Compar, VCF sample ID support in SnpGenotypeComparer with error handling for multi-ID scenarios, and credential management improvements by sourcing GCP signed URL credentials from Secrets Manager.

October 2024 monthly summary focusing on key deliverables and impact across two repositories. The team concentrated on stabilizing the build pipeline, upgrading the runtime base, and improving documentation to reflect the current data model. This work reduces risk of build failures, improves maintainability, and supports downstream CI/CD reliability for consumers of these projects.